Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Cited by (1,000)

Items 701–800 of 1,000

1. Novel Oral Anticoagulants: A Review of the Literature and Considerations in Special Clinical Situations
   Frank Akwaa, Alex C. Spyropoulos · 2013 · Hospital Practice
2. Long-term bleeding events after mechanical aortic valve replacement in patients under the age of 60
   Ben M. Swinkels, Bas A.J.M. de Mol, Johannes C. Kelder, Freddy E.E. Vermeulen, Jurriën M. ten Berg · 2014 · Netherlands Heart Journal
3. The New Era of Anticoagulation
   Nedaa Skeik, Kyle K. Rumery, Gabriel T. Rodriguez · 2013 · Annals of Vascular Surgery
4. Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging “Real-World” Questions
   Jorge Ferreira, Daniel Ferreira, Miguel Viana Baptista, Paulo Bettencourt, Rui Cernadas, Francisco Crespo · 2012 · Thrombosis
5. Antithrombotic treatment in elderly patients with atrial fibrillation
   Carmen Suárez Fernández, Miguel Camafort, J.M. Cepeda Rodrigo, Jesús Díez‐Manglano, Francesç Formiga, Antonio Pose Reino, Gregorio Tiberio, José M. Mostaza · 2015 · Revista Clínica Española (English Edition)
6. The Case for an Elderly Targeted Stroke Management
   Osvaldo Fustinoni · 2011 · Frontiers in Neurology
7. Current Evidence for New Oral Anticoagulants in the Treatment of Nonvalvular Atrial Fibrillation: Comparison of Substudies
   Antoni Martínez‐Rubio, Roger Martínez-Torrecilla · 2014 · Revista Española de Cardiología (English Edition)
8. Implications of Edoxaban in the Prevention and Treatment of Thromboembolic Complications in Clinical Practice
   Vivencio Barrios, Carlos Escobar · 2016 · Future Cardiology
9. Age as a Risk factor for Atrial Fibrillation and Flutter after Coronary Artery Bypass Grafting.
   Prashant Dattatraya Bhave, ROD S. PASSMAN · 2012 · Europe PMC (PubMed Central)
10. Antithrombotic Therapy in Nonvalvular Atrial Fibrillation: Consensus and Challenges
    Furqan Habib Khattak, Mian Bilal Alam, Timir Kumar Paul, Shasank Rijal, Shoaib Wazir, Carl J. Lavie, Samir Saba · 2018 · The American Journal of the Medical Sciences
11. Atrial fibrillation in old age: risk management and features of the use of direct oral anticoagulants
    С. Г. Канорский · 2021 · Kardiologiia
12. The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways
    Kori Leblanc, Jenny MacGillivray, Amanda Carroccia, Laurent Macle, Jason G. Andrade · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
13. Outcome of novel oral anticoagulant versus warfarin in frail elderly patients with atrial fibrillation: a systematic review and meta-analysis of retrospective studies
    Jingjing Hu, Yidan Zhou, Zhaobin Cai · 2023 · Acta Clinica Belgica
14. Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study
    Mauro Molteni, Matteo Crippa, Annalisa Orenti, Hernan Polo Friz, Anna Menghini, Pierluigi Tramacére, Giuseppe Marano, Claudio Cimminiello, Patrizia Boracchi · 2019 · Clinical Drug Investigation
15. Patient Taking A Novel Oral Anticoagulant Presents With Major GI Bleeding.
    Amartya Kundu, Partha Sardar, Parijat Sen, Saurav Chatterjee, Jessica Huston, Ramez S. Nairooz, John Jake Ryan, Wilbert S. Aronow · 2015 · Europe PMC (PubMed Central)
16. Association between body mass index and the risk of bleeding in elderly patients with non-valvular atrial fibrillation taking dabigatran: a cohort study.
    Minghui Li, Lihua Hu, Yurong Xiong, Yu Yu, Wei Zhou, Tao Wang, Lingjuan Zhu, Xi Liu, Huihui Bao, Xiaoshu Cheng · 2020 · PubMed Central
17. Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
    Alicia de Felipe Mimbrera, Araceli Alonso Cánovas, Marta Guillán, Consuelo Matute, Susana Sainz de la Maza, Antonio Cruz, Rocío Vera, Jaime Masjuán · 2014 · BioMed Research International
18. Anticoagulant therapy in the elderly
    Debora Karetová, Jan Bultas · 2018 · Vnitřní lékařství
19. Learning the Respective Roles of Warfarin and Dabigatran to Prevent Stroke in Patients With Nonvalvular Atrial Fibrillation
    Rebecca J. Beyth, C. Seth Landefeld · 2011 · Annals of Internal Medicine
20. Anticoagulants beyond coagulation: a narrative review of cardiovascular effects
    Annisa Aarts, Hugo Ten Cate, Arina J. ten Cate‐Hoek · 2026 · Cardiovascular Research
21. Practical Management of Stroke Prevention in Patients with Atrial Fibrillation and Renal Impairment Receiving Newer Oral Anticoagulants:Focus on Rivaroxaban
    Jafna L. Cox · 2014 · Journal of General Practice
22. Benefit–Risk Assessment of Dabigatran in the Treatment of Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sascha Meyer dos Santos, Sebastian Harder · 2014 · Drug Safety
23. A novel oral anticoagulant, dabigatran, in acute renal infarction
    Cihan Altın, Onur Sakallıoğlu, Esin Gezmiş, Haldun Müderrisoğlu · 2015 · The Anatolian Journal of Cardiology
24. Reconsideration of Key Articles Regarding Medication-Related Problems in Older Adults from 2011
    Carolyn T. Thorpe, Holly C. Lassila, Christine Karabin O’Neil, Joshua M. Thorpe, Joseph T. Hanlon, Robert L. Maher · 2012 · The American Journal of Geriatric Pharmacotherapy
25. Nuevas perspectivas clínicas en el uso de los anticoagulantes orales directos
    Pascual Marco, José Luis Zamorano, Francisco Chana, Juan V. Llau · 2013 · Medicina Clínica
26. Switching from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose
    Naja Emborg Vinding, Laila Stærk, Gunnar Gislason, Christian Tobias Torp-Pedersen, Anders Nissen Bonde, Rasmus Rørth, Christina Ji‐Young Lee, Jonas Bjerring Olesen, Lars Køber, Emil Loldrup Fosbøl · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
27. Occlusion of Bilobulated Left Atrial Appendage Using the Dual-Watchman Technique: A Long-Term Follow-Up Study
    Tao Chen, Qingsong Wang, Ge Liu, Lu Xu, Tingting Song, Ming-yuan Shi, Hang Zhu, Yang Mu, Jun Guo, Yundai Chen · 2022 · Frontiers in Cardiovascular Medicine
28. The risk of bleeding with anticoagulant treatments
    Gualtiero Palareti · 2011 · Phlebologie
29. Cardiovascular risk factors in elderly : With special emphasis on atrial fibrillation, hypertension and diabetes
    Karin Rådholm · 2015 · Linköping University medical dissertations
30. Novel Oral Anticoagulants for Stroke Prevention in the Geriatric Population
    Daniel Kim, Richard Barna, Mary Barna Bridgeman, Luigi Brunetti · 2013 · American Journal of Cardiovascular Drugs
31. Antithrombotic Therapy During and After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Freek W.A. Verheugt · 2013 · Circulation
32. Clinical utility of dabigatran in United Arab Emirates
    Abdulla Shehab, Asim Ahmed Elnour, Adel Shaban Sadeq, Mahmoud Abu Mandil, Ali Alshamsi, Aeshal Al Suwaidi, Akshaya Srikanth Bhagavathula, Pınar Erkekoğlu, Farah Hamad, Saif K. Al Nuaimi · 2015 · Saudi Medical Journal
33. Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function
    Thin Thin Maw, Brian L. Henry, Tripti Singh · 2014 · Clinical Nephrology - Case Studies
34. Resuming Anticoagulation following Upper Gastrointestinal Bleeding among Patients with Nonvalvular Atrial Fibrillation�A Microsimulation Analysis
    Matthew A. Pappas · 2019 · Journal of Hospital Medicine
35. Gastrointestinal Endoscopy in Patients on Direct Oral Anticoagulants. A Consensus Paper of the Romanian Society of Gastroenterology and Hepatology
    Andreea Maria Farcas, Simona Maria Bataga, Cristina Cijevschi, Mircea Diculescu, Daniela Ecaterina Dobru, Eugen Dumitru, Adrian Goldiș, Laurențiu Dănuț Nedelcu, Alina Popescu, Ioan Sporea et al. · 2018 · Journal of Gastrointestinal and Liver Diseases
36. Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment
    Н. С. Лапина, A. A. Alekseeva, A. D. Vershinina, Н. С. Хрулева, Ф. Н. Мурадова, L. Y. Koroleva · 2020 · Russian Journal of Gastroenterology Hepatology Coloproctology
37. Risk of left atrial appendage thrombus in older patients with atrial fibrillation
    Monika M. Gawalko, Monika Budnik, Beata Uziębło‐Życzkowska, Iwona Gorczyca−Michta, Paweł Krzesiński, Piotr Ścisło, Janusz Kochanowski, Anna Michalska, Olga Elżbieta Jelonek, Katarzyna Starzyk et al. · 2021 · Archives of Medical Science
38. Self-care training and informational support of patients with a mechanical heart valve on the international normalized ratio and bleeding complications
    Shirdel Zandi, Behzad Imani, Gholamreza Safarpour · 2021 · Polish Journal of Cardio-Thoracic Surgery
39. Management of atrial fibrillation and anticoagulant therapies
    Mark D O'Neill, John Whitaker, Jonathan Birns, Matthew James Wright · 2017
40. Small bowel intramural hematoma caused by warfarin: case report and literature review
    Zihao Wang, Tianxiang Jiang, Mingchun Mu, Chaoyong Shen, Zhaolun Cai, Hai‐Ning Chen, Bo Zhang · 2024 · Scandinavian Journal of Gastroenterology
41. The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis
    Piyameth Dilokthornsakul, Unchalee Permsuwan · 2021 · Expert Review of Pharmacoeconomics & Outcomes Research
42. Spontaneous Quadriceps Hematoma in an Elderly Adult Taking Therapeutic Doses of Warfarin
    Justin Linghui Chew, Selvaganapathi Natesan, Wee Shiong Lim · 2013 · Journal of the American Geriatrics Society
43. Is the warfarin saga over?
    Sam Schulman · 2012 · The Journal of the Royal College of Physicians of Edinburgh
44. Evaluation and Management of the Atrial Fibrillation Patient
    Benjamin Adam Steinberg, Philip D. Beckley, Thomas F. Deering, Carol Lynn Clark, Alpesh Amin, Kenneth Alan Bauer, Byron Cryer, MOUSSA C. MANSOUR, James M. Scheiman, Marco A. Zenati et al. · 2013 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
45. Nuevos anticoagulantes orales: el dilema de la anticoagulación en el anciano
    José Antonio Páramo · 2013 · Medicina Clínica
46. Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?
    Jun R. Chiong, Rebecca J Cheung · 2013 · Korean Circulation Journal
47. Neue Antikoagulanzien zur Schlaganfallprävention bei Vorhofflimmern
    HC Diener, Karim Hajjar, Benedikt Frank, Mareike Perrey · 2012 · Herz
48. Is there really misuse and abuse of dabigatran?
    John W. Eikelboom, Graeme J. Hankey · 2013 · The Medical Journal of Australia
49. Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban
    Jaime Masjuán, Alicia DeFelipe · 2016 · International Journal of Neuroscience
50. Treatment of postoperative atrial fibrillation: The long road ahead
    Dawn S. Hui, Richard Lee · 2019 · Journal of Thoracic and Cardiovascular Surgery
51. Guidelines for perioperative antithrombotic therapy in hair restoration surgery: management of patients with coronary heart disease, mechanical heart valve, and atrial fibrillation
    Kuniyoshi Yagyu · 2012 · International Society of Hair Restoration Surgery
52. Letter by Reiffel Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial”
    James A. Reiffel · 2012 · Circulation
53. Device-detected atrial tachyarrhythmias: what do we know?
    Jeff S. Healey · 2011 · EP Europace
54. How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group.
    Andrea Rubboli, Claudio Fresco, Maurizio Paciaroni, Bianca Rocca, Domenico Pecora, Iolanda Enea, Claudio Cuccia, Giuseppe Patti · 2021 · PubMed
55. Anticoagulation in Frail Older Adults with Non-Valvular Atrial Fibrillation: Clinical Challenges and Personalized Approach
    Elisa Fabbri, Lorenzo Maestri, Paolo Muratori · 2025 · Journal of Clinical Medicine
56. Dabigatran for stroke prevention in atrial fbrillation
    Helen Williams · 2012 · British Journal of Cardiac Nursing
57. Optimizing the dose of dabigatran etexilate
    John Posner · 2012 · British Journal of Clinical Pharmacology
58. Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran
    Christopher P. Ingelmo, Oussama M. Wazni · 2011 · Current Cardiology Reports
59. Oral anticoagulants in older adults with atrial fibrillation
    Gwen M. Bernacki, Richard Clinton Becker · 2013 · Journal of Thrombosis and Thrombolysis
60. Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants
    Masahiro Yasaka, Yasushi Okada · 2012 · Rinsho Shinkeigaku
61. Farmacología de dabigatrán y su manejo clínico
    Juan Fernández‐Armenta, Josép Brugada · 2012 · Revista Española de Cardiología Suplementos
62. Revisión de los resultados de los principales subestudios del estudio RE-LY
    Gonzalo Barón‐Esquivias, Nieves Romero, Agustín Guisado Rasco, Jaime Nevado, Ángel Martı́nez · 2012 · Revista Española de Cardiología Suplementos
63. Cross-trial comparisons: A source of confusion, use, or both in the management of patients with atrial fibrillation?
    Vivek Iyer, Daniel Y. Wang, James A. Reiffel · 2013 · American Heart Journal
64. Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents
    Marjorie Kayser, Y. Francès, Laurent Bonello, Franck F. Paganelli, Michaël Peyrol · 2014 · European Journal of Internal Medicine
65. Anticoagulation for Atrial Fibrillation in the Elderly
    Deepika Narasimha, Anne B. Curtis · 2015 · Archives of Medicine
66. Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation
    Sotiris Antoniou, W. Amara · 2016 · European Heart Journal Supplements
67. Use of Direct Oral Anticoagulants in Special Populations
    Ang Li, Renato D. Lópes, David A. Garcia · 2016 · Hematology/Oncology Clinics of North America
68. Intracranial hemorrhage during administration of a novel oral anticoagulant
    Akira Tempaku · 2016 · Journal of Rural Medicine
69. Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
    Suguru Tokiwa, Hiroaki Shimmura, Shuhei Nomura, Ryota Watanabe, Minoru Kurita, Naoto Yoshida, Kaori Yamashita, Yoshitaka Nishikawa, Alexander Kouzmenko, Shigeaki Kato · 2017 · Research and Reports in Urology
70. Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
    Ol'ga Dmitrievna Ostroumova, E. A. Volkova, А. И. Кочетков, Anton P. Pereverzev, О. Н. Ткачева · 2019 · CARDIOVASCULAR THERAPY AND PREVENTION
71. Comparison of Low and Full Dose Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Renal Dysfunction (from a National Registry)
    Chen Gurevitz, Ela Giladi, Alon Barsheshet, Robert Klempfner, Ilan Goldenberg, Ran Kornowski, Avishay Elis · 2021 · The American Journal of Cardiology
72. The first experience of a hybrid approach in the surgical treatment of atrial fibrillation
    Aleksandr S. Zotov, Igor A. Khamnagadaev, Сахаров Эмиль Романович, Oleg O. Shelest, Белоусов Леонид Александрович, Mikhail L. Kokov, Marina Sergeevna Michurova, Irina Andreevna Bulavina, Robert I. Khabazov, Natalya G. Mokrysheva et al. · 2023 · Journal of clinical practice
73. A Closer Look into Gastrointestinal Bleeding in Heart Failure Patients
    Anas Zaher, Jude ElSaygh, Akram Midani, Andrew M. Treihaft, Brinda Banerji, Muhammad F. Bouso, Malik Mushannen, Rawan Hussein, Carl V. Crawford · 2024 · Current Problems in Cardiology
74. Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
    M. Fernandez, B von Scheele, S. Hogue, Winghan Jacqueline Kwong · 2013 · American Journal of Cardiovascular Drugs
75. Excessive Prolongation of Coagulation Time During Treatment With Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation
    Mihoko Kawabata, Masahiko Goya, Yoshihide Takahashi, Shingo Maeda, Atsuhiko Yagishita, Masahiro Sekigawa, Kikou Akiyoshi, Tasuku Yamamoto, Takatoshi Koyama, Kenzo Hirao · 2019 · Canadian Journal of Cardiology
76. Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology
    Бельдиев Сергей Николаевич, И. В. Медведева, D. Yu. Platonov, G. Yu. Trufanova · 2019 · Rational Pharmacotherapy in Cardiology
77. Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
    Е. И. Баранова, Zhanna Kobalava · 2019 · Russian Journal of Cardiology
78. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding
    Veronica Ojetti, Angela Saviano, Mattia Brigida, Luisa Saviano, Alessio Migneco, Francesco Franceschi · 2020 · Reviews on Recent Clinical Trials
79. Left Atrial Appendage Closure Is Preferred to Chronic Warfarin Therapy
    Moustapha Atoui, Sampath Gunda, Dhanunjaya Lakkireddy · 2015 · Cardiac Electrophysiology Clinics
80. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Jorge D. Korin · 2012 · PubMed
81. Novel Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation
    Jeremy P. Berman, Jonathan L. Halperin · 2013 · Hospital Practice
82. Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
    Luciana Armaganijan, Dimpi Patel, Cristiano de Oliveira Dietrich, Carlos Arturo Morillo · 2012 · Pharmaceuticals
83. Balancing Efficacy and Bleeding Risk in the Prevention of Stroke Due to Atrial Fibrillation with Newer Oral Anticoagulants
    M B Agarwal, Subhash Verma, Manoranjan Mahapatra, Anil Kumar Tripathi, Abhay A. Bhave, Anand Deshpande, Amit M. Vora, Jamshed J Dalal, Anuj Shah, Shrirang Bichu · 2012 · Indian Journal of Hematology and Blood Transfusion
84. Impact of Atrial Fibrillation on Outcomes in Heart Failure
    Eugene Christopher DePasquale, Gregg C. Fonarow · 2013 · Heart Failure Clinics
85. Effectiveness and Safety of Therapy with Vitamin K Antagonists in Italian Patients Aged 80 Years or Older: a Multicentre Retrospective Study Comparing the Zeus Algorithm with the PARMA Algorithm or Manual Therapy
    Arturo Cafolla, Luigia Manisco, Erminia Baldacci, Alessandro Porcu, Melissa Campanelli, Maria Concetta Cursano, Enza Rossi, Francesco Dragoni, Roberto Foà · 2015 · Drugs & Aging
86. Decennial Analysis of Interventional Left Atrial Appendage Closure
    Boris Schmidt, Stefano Bordignon, Alexander Fuernkranz, Laura Perrotta, Detlef Scherer, K. R. Julian Chun · 2015 · Journal of Cardiovascular Electrophysiology
87. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary
    Jonathan W. Waks, PETER J. ZIMETBAUM · 2013 · Expert Review of Cardiovascular Therapy
88. The Need for a Coagulation Assay after Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report
    Mi Ji Lee, Hye Min Jang, Woo Kyo Jeong, Oh Young Bang · 2015 · Journal of Clinical Neurology
89. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease
    Mohit K. Turagam, Naga Saranya Addepally, Poonam Velagapudi · 2013 · Expert Review of Cardiovascular Therapy
90. Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?
    Freek W.A. Verheugt · 2012 · American Heart Journal
91. New Oral Anticoagulants in Non-Valvular Atrial Fibrillation
    Pietro Francia, Carmen Adduci, Daria Santini, Beatrice Musumeci, Giuliano Tocci · 2013 · High Blood Pressure & Cardiovascular Prevention
92. Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants
    Ayrton Roberto Massaro, Robert Patrick Giugliano, Bo G Norrving, Ali Oto, Roland C. Veltkamp · 2016 · International Journal of Stroke
93. Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
    Arash Alipour, Lisette I S Wintgens, Martin John Swaans, Jippe C. Balt, Benno J.W.M. Rensing, Lucas V.A. Boersma · 2017 · Vascular Health and Risk Management
94. Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Non-Valvular Atrial Fibrillation
    Semira Abdi Beshir, Lok Bin Yap, Szyuin Sim, Kok Han Chee, Yoke Lin Lo · 2017 · Journal of Pharmacy & Pharmaceutical Sciences
95. Rivaroxaban in high-risk patients
    Jindřich Špinar, Lenka Špinarová · 2017 · Vnitřní lékařství
96. 2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
    Jin‐Kyu Park, Jun Kim, Yong‐Soo Baek, So‐Ryoung Lee, You Mi Hwang, Tae-Hoon Kim, Dae In Lee, Ki Hong Lee, Jaemin Shim, Boyoung Joung · 2019 · Korean Journal of Medicine
97. Management von intrazerebralen Blutungen unter oraler Antikoagulation
    Jochen A. Sembill, Joji B. Kuramatsu, S. H. Hohnloser, Hagen Bernhard Huttner · 2019 · Herz
98. Intracerebral Hemorrhage
    Carlos S. Kase, Ashkan Shoamanesh, Steven Mark Greenberg, Louis R. Caplan · 2015 · Elsevier eBooks
99. Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF
    Sake J. van der Wall, Christine Teutsch, Sérgio Dubner, Hans‐Christoph Diener, Jonathan L. Halperin, Chang Sheng, Kenneth Jay Rothman, Miney Paquette, Kristina Zint, Lionel Riou França et al. · 2021 · TH Open
100. Which therapy for which condition?
     Bernard John Gersh, Lionel Henry Opie · 2013 · Elsevier eBooks